Kidney Failure clinical trials

Explore recruiting kidney failure clinical trials.

Recruiting kidney failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease

Netherlands, Germany, Belgium, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Proof of Concept Study Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Dual Targeting Of Peripheral And Central Humoral Alloimmune Memory With Anti-CD38 (Daratumumab) And Costimulation Blockade With CTLA4-Ig (Belatacept) In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

(21177) A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease

Bulgaria, Denmark, Spain, Czechia, Hungary, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants with Chronic Kidney Disease and High Blood Pressure.

Sweden, Czechia, Germany, Spain, Poland, Belgium +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients

Netherlands, Norway, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Kidney Failure trials by city

Kidney Failure in Toronto Kidney Failure in Vancouver Kidney Failure in Montreal Kidney Failure in Calgary Kidney Failure in Edmonton Kidney Failure in Ottawa Kidney Failure in Winnipeg Kidney Failure in Quebec City Kidney Failure in Hamilton Kidney Failure in Kitchener Kidney Failure in London Kidney Failure in Halifax Kidney Failure in New York Kidney Failure in Los Angeles Kidney Failure in Chicago Kidney Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease